Pharmafile Logo
Pharmafocus logo
Advanced Search

OSE Immunotherapeutics Announces First Patient Dosed with Anti-PD1 Monoclonal Antibody OSE-279 in a Phase 1/2 Clinical Trial in Advanced Solid Tumors or Lymphomas

December 22, 2022
Business Services

Nantes, France – December 22,

News
Press release

Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery

December 21, 2022
Medical Communications

LONDON, UK, 21st December 2022 — RQ Bio announces that the first of its discovered monoclonal antibodies to prevent COVID-19 …

News
Press release

Kite set to acquire Tmunity Therapeutics

December 21, 2022
Medical Communications

Santa Monica, US-based Kite is set to acquire Philadelphia, US-based Tmunity Therapeutics: a clinical stage, private biotech company. The financial …

News

Two biotech CEOs charged with defrauding investors over investigational HIV drug

December 21, 2022
Medical Communications

Two US biotech CEOs have been highlighted for their roles in a conspiracy to defraud investors in CytoDyn, a company …

News

Gambia panel recommends Maiden Pharmaceuticals be held culpable for cough syrup deaths

December 21, 2022
Medical Communications

A parliamentary committee in The Gambia has recommended prosecution of the Indian pharma manufacturer Maiden Pharmaceuticals, as they have sold …

News

Tamiflu manufacturers report shortages during high point of flu season

December 21, 2022
Medical Communications

The CDC has reported at least 23,000 hospitalisations due to influenza while this year’s flu season is at a high …

News

Sosei Heptares’ Partner Pfizer Progresses its Oral GLP-1 Receptor Agonist PF-07081532 into Phase 2 Clinical Trials for Treating Type 2 Diabetes and Obesity

December 21, 2022
Business Services

Tokyo, Japan and Cambridge, UK, 21 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

Poolbeg identifies new potential drug candidates for Respiratory Syncytial Virus infections as part of Artificial Intelligence Programme

December 21, 2022
Business Services

Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical company, announces that it …

News
Press release

NICE EXTENDS USE OF ENHERTU® ▼ (TRASTUZUMAB DERUXTECAN) TO EARLIER IN THE TREATMENT OF HER2 POSITIVE METASTATIC BREAST CANCER

December 20, 2022
Business Services

Uxbridge and London, UK – (20 December 2022) – Daiichi Sankyo UK Limited and AstraZeneca UK Limited today welcome the …

News
Press release

Idorsia submits new drug application to FDA for aprocitentan to treat difficult-to-control hypertension

December 20, 2022
Research and Development

Idorsia has announced that it has submitted a new drug application (NDA) to the FDA in hopes of gaining approval …

News

AlzeCure has abstract accepted on possible disease-modifying effects of ACD856 against Alzheimer’s

December 20, 2022
Research and Development

AlzeCure, a pharma company who focuses on its portfolio of small molecule candidate drugs for central nervous system (CNS) diseases, …

News
carlos-muza-hpjsku2uysu-unsplash

ServBlock secures EU funding for pharma manufacturing data space

December 20, 2022
Medical Communications

ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system …

News

Abbott’s Eterna spinal cord stimulation system given FDA approval

December 20, 2022
Medical Communications

US-based Abbott Laboratories has announced that their Eterna spinal cord stimulation (SCS) system has been given approval by the FDA. …

News

Unison boss states Government has “adamantly refused” to engage in a “proper discussion” on pay ahead of Wednesday’s ambulance strikes

December 19, 2022
Medical Communications

Unison general secretary Christina McAnea has said that Wednesday’s ambulance strikes will go ahead without a “very firm commitment” on …

News

FDA approves first gene therapy to treat patients with high-risk, non-muscle-invasive bladder cancer

December 19, 2022
Medical Communications

The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive …

News

New study shares effectiveness of asthma drug compared to standard of care

December 19, 2022
Research and Development

The University of Plymouth has co-authored a new study, published in The Lancet, which shows how an asthma drug, commercially …

News

Targeted imaging agent for lung cancer surgery approved by FDA

December 19, 2022
Research and Development

The FDA has approved Cytalux (pafolacianine) to be used in lung cancer surgery: the targeted imaging agent binds to cancerous …

News

Psoriasis community comes together and calls for collective action to help improve the lives of people with psoriasis

December 19, 2022
Business Services

Slough, UK, 15 December 2022 – UCB, a global biopharmaceutical company, has announced results from the Epicensus programme, published in …

News
Press release

Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases

December 19, 2022
Business Services

Tokyo, Japan and Cambridge, UK, 16 December 2022 – Sosei Group Corporation (“the Company”; TSE: 4565) announces it has entered …

News
Press release

Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UK to accelerate development of disease-modifying therapy for Huntington’s Disease

December 19, 2022
Business Services

Cambridge, UK. December 16 2022 – Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today …

News
Press release
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026